Wed.Mar 12, 2025

article thumbnail

Pharma Marketing Keyword Research for PPC

Pharma Marketing Network

Table of Contents Why Keyword Research for PPC Matters in Pharma Marketing Understanding Pharma-Specific PPC Challenges Best Practices for Pharma Keyword Research Optimizing PPC Campaigns for Compliance and ROI Why Keyword Research for PPC Matters in Pharma Marketing Keyword research for PPC is the foundation of any successful pharma marketing strategy.

FDA
article thumbnail

Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change

PhRMA

Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients. Specifically, HCPs raised concerns over how pharmacy benefit managers (PBMs) and insurers inappropriately use utilization management tools, like prior authorization, to deny or delay care, ultimately harming the patient and impacting patient access to care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Montelukast Causes The Prescribing Cascade – Case Study

Med Ed 101

SM is a 48-year-old female who has new-onset symptoms of restlessness, irritability, insomnia, and vivid nightmares. Over the past 3 months, she has also experienced increasing anxiety and mood swings. She reports a feeling of impending doom and difficulty concentrating, which has begun to affect her daily life and work performance. She has a past […] The post Montelukast Causes The Prescribing Cascade – Case Study appeared first on Med Ed 101.

article thumbnail

PQA’s Six Objectives to Advance MTM Quality

PQA

The evolution of PQAs continued involvement in medication therapy management (MTM) spans over a decade. Milestones include endorsement of the Completion Rate for Comprehensive Medication Review performance measure in 2011 and development of the foundational Medication Therapy Problem Categories Framework in 2017. In 2023, PQA launched a multiphase national MTM initiative to address stakeholder needs and advance MTM quality measurement.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How NF2 Affects Me – The Exhibition (2025)

NF2 BioSolutions

From 25 th February until Rare Disease Day (28 th February), NF2 BioSolutions UK & Europe held an exhibition at the Nottingham Central Library to raise awareness of NF2 and to shine a light on those with NF2 who have bravely shared their stories with us for our popular social media campaign. [IMAGE DESCRIPTION] The NF2 BioSolutions Exhibition stall at Nottingham Central Library, with a standing banner describing the origin and effects of NF2-SWN, and a table full of posters telling the indiv

article thumbnail

ACI’s 21st Annual Paragraph IV Disputes

The FDA Law Blog

The American Conference Institutes 21st Annual Paragraph IV Disputes is scheduled to take place from April 29-30, 2025 at The Altman Building in New York, NY. Widely recognized as the industry gold standard, the conference unites leaders from brand-name and generic drug companies, alongside federal judges, the U.S. PTOs PTAB, the FTC, and the FDA, to tackle the critical legal, regulatory, and business issues shaping pharmaceutical patent litigation.

FDA

More Trending

article thumbnail

The end-of-life doula: Making smooth the paths of people on the journey to death

STAT

For the Rev. Beth Stotts, death is a natural part of her ministry. A major aspect of her job is guiding her congregants through their most vulnerable moments from birth throughout life. The struggles she has seen in her community led her to seek more training to help people face death, and in 2022 she added another credential to her spiritual one: end-of-life doula.

article thumbnail

Healthcare Research Essentials: Health & Life Sciences Conference Directory – 2025 

Fuld

The ultimate guide to 2025 healthcare and life sciences conferences Stay ahead of the latest developments and networking opportunities in the health and life sciences sector with Fulds 2025 Health & Life Sciences Conference Directory. This comprehensive resource provides a detailed calendar of key healthcare conferences happening across the US and Europe in 2025, all in a single, easy-to-access document.

article thumbnail

STAT+: Should health care providers tell patients they are using AI? 

STAT

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine.  Sign up to get it  delivered in your inbox every Wednesday.   Patients prefer messages that are written by AI, but they like them less when they’re told the message was AI-drafted, says a new study that came out yesterday in JAMA Network Open.

article thumbnail

CagriSema Demonstrates Significant Weight Loss at 68 Weeks

Drug Topics

Approximately 89.7% of patients taking CagriSema achieve the coprimary end point of weight loss of 5% or more compared with 30.3% on the placebo.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more

STAT

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is, once again, maple cinnamon French toast.

article thumbnail

Bleeding Disorders Significantly Impact Quality of Life Among Women

Drug Topics

Researchers analyzed historical characteristics of bleeding disorders among women by highlighting clinical challenges and management strategies.

article thumbnail

Opinion: Carl Zimmer on Covid, singing, and going ‘Air-Borne’

STAT

Tuesday marked the fifth anniversary of the World Health Organization declaring Covid-19 a global pandemic. For science writer Carl Zimmer, a columnist for the New York Times, covering Covid meant “watching [scientists] figuring out this disease in real time.” Notably, “there were a lot of mysteries about it. I was really struck as, as others were, by how strange it was that, that the just a fundamental question of how Covid spread was so unclear and was leading to so much a

article thumbnail

Q&A: Who is Responsible for Addressing the Growing Issue of Pharmacy Deserts?

Drug Topics

Representatives from Cencoras Good Neighbor Pharmacy Network discussed legislation created to improve declining pharmacy rates and who is accountable for addressing pharmacy deserts.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Warren asks HHS watchdog to investigate GSK over its asthma inhaler maneuvers

STAT

After a year of controversy and complaints, U.S. Sen. Elizabeth Warren (D-Mass.) is asking a federal watchdog to investigate GSK for replacing a popular asthma inhaler with a so-called authorized generic at a much higher price in order to avoid paying Medicaid rebates. In a letter sent Tuesday to the Office of Inspector General at the U.S. Department of Health and Human Services, Warren accused the company of “outrageous profiteering” because the maneuver cost Medicaid nearly $1 bi

article thumbnail

Baricitinib Shows Significant Hair Regrowth for Pediatric Patients With Alopecia Areata

Drug Topics

Patients aged 12 to under 18 saw clinically meaningful regrowth on the scalp, eyebrow, and eyelashes with both high-dose and low-dose treatment.

article thumbnail

STAT+: Roche partners with Zealand Pharma to push forward obesity drug

STAT

LONDON — Looking to expand its obesity offerings, Roche on Wednesday said it had partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion in upfront cash. The Swiss pharma giant and the Danish biotech will now work together to develop Zealand’s drug candidate petrelintide, aiming to test it on its own and in combination with Roche’s experimental CT-388.

article thumbnail

Deucravacitinib Shows Improvement in Symptoms of Psoriatic Arthritis

Drug Topics

Deucravacitinib (Sotyktu) also demonstrates improvements in signs and symptoms, extra-articular manifestations, and patient-reported outcomes.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: CDC’s reported study on vaccines and autism could test RFK Jr.’s pledges to a key senator

STAT

Reports of a new federal plan to study whether there’s a link between vaccines and autism could serve as an early test of the commitments Sen. Bill Cassidy (R-La.) said he received from Robert F. Kennedy Jr. in exchange for his support for RFK Jr.’s confirmation as Health and Human Services secretary. On Friday, multiple news outlets reported that the Centers for Disease Control and Prevention was planning the study.

article thumbnail

Oral Antiviral Demonstrates Prevention of COVID-19 in Phase 3 Study

Drug Topics

Ensitrelvir demonstrated a 67% relative risk reduction of developing symptomatic COVID-19 in household contact patients.

article thumbnail

The COVID-19 Pandemic: 5 Years Later

Pharmacy Times

The pandemic showcased the resiliency and adaptability of pharmacists.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

A long-term project from contractors to modernize a provider enrollment system for Medicare is the latest casualty of DOGE and will now be completed in-house, the agency recently announced. Whether that decision is a good or bad one is up for debate.

article thumbnail

Study Finds Elevated RSV Hospitalization Rates in Patients With Asthma, COPD

Pharmacy Times

Adults with asthma or COPD face a heightened risk of RSV-related illness.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Notify.gov, a mass texting service created to better communicate renewal deadlines and eligibility for benefit programs like Medicaid, will not be operational.

article thumbnail

SAMHSA employees detail an agency in shambles

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Hello all, this is Allison DeAngelis, filling in for your Morning Rounds maven Theresa Gaffney.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

A recent analysis, which looked at ophthalmology practice acquisitions between 2014 and 2021, outlines movement among the clinical workforce and changes in its characteristics that stem from private equity's increasing role in care.

article thumbnail

Lilly CEO got a big payday (and an Olympics treat)

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, hope everyone is enjoying the warmer weather and longer days. Let’s get into the news today.

article thumbnail

Ono earmarks $940m to gain rare blood cancer therapy from Ionis

Pharmaceutical Technology

Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia vera (PV).

article thumbnail

Dexamethasone Shows Promise as Cost-Effective Alternative to Tocilizumab for Cytokine Release Syndrome in RRMM

Pharmacy Times

Use of dexamethasone over tocilizumab was associated with significant cost-savings for patients with relapsed/refractory multiple myeloma (RRMM).

article thumbnail

Roche builds in obesity with $5.3bn Zealand licensing deal

pharmaphorum

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma.

article thumbnail

MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations and a Data Breach

Pharmacy Times

The health care community was left largely unaware of the controversy that occurred at one of the clinical trial sites.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Some health tech companies help providers communicate more proactively with patients about what they might owe and what repayment options are available to them.

article thumbnail

MSD opens $1bn plant for HPV vaccine in the US

pharmaphorum

MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.